Hinduja Global Solutions (HGS) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
2 Nov, 2026Executive summary
Q1 FY2026 operating revenue was Rs. 1,056.23 crore, EBITDA Rs. 159.7 crore at a 13.5% margin, and consolidated PAT Rs. 11.16 crore.
Margin expansion and a shift toward digital, AI-enabled operations remained priorities amid macro volatility, seasonality and client ramp-downs.
Added 18 digital CX logos and 14 HRO/payroll clients, and expanded core CX and digital engagements with 65 existing clients.
Financial highlights
Operating revenue was Rs. 1,056.23 crore versus Rs. 1,091.92 crore YoY and Rs. 1,161.1 crore in Q4 FY2025; total income was Rs. 1,187.3 crore.
EBITDA was Rs. 159.7 crore versus Rs. 143.4 crore YoY and Rs. 279.2 crore in Q4 FY2025; margin was 13.5%.
Consolidated PAT was Rs. 11.16 crore, including Rs. 57.5 crore from discontinued operations; continuing-operations PAT was a loss of Rs. 46.33 crore.
Depreciation was Rs. 128.3 crore and interest expense Rs. 57.9 crore; operating expenses were Rs. 1,027.5 crore.
Outlook and guidance
Digital and Digital Operations accounted for nearly 60% of the Americas pipeline; another estimate put digital services above 55% of the regional order pipeline.
Priorities include BFSI, Retail & CPG, Healthcare and UK public sector, with a mid-market focus, consultative sales and vertical PaaS development.
Strategy centers on intelligent experiences, integrating technology, data and human empathy; digital and AI-enabled operations are expected to support a higher-quality revenue mix.
A new AI-powered Digital CX and Data Innovation Hub opened in Waterloo, Canada.
Latest events from Hinduja Global Solutions
- Q2 operating EBITDA rose 30% as cost discipline offset muted growth.HGS
Q2 23/24 - Q3 EBITDA surged and PBT turned positive amid digital growth and uncertain demand.HGS
Q3 23/24 - FY2024 operating EBITDA rose 45.8% as AI-led growth advanced amid unresolved tax-search exposure.HGS
Q4 23/24 - One-time costs pressured margins; healthcare-sale gain lifted PAT, with recovery expected from Q2.HGS
Q1 24/25 - UK and macro headwinds cut revenue as technology and AI initiatives advanced.HGS
Q2 24/25 - FY25 PAT included a healthcare-sale gain as strategy pivots to AI-led digital growth.HGS
Q4 24/25 - Q3 EBITDA margin reached 19% as AI-led growth advanced amid near-term revenue pressure.HGS
Q3 24/25 - FY26 EBITDA fell 20.1%; record wins and Project GANGA support growth prospects.HGS
Q4 25/26 - Revenue held broadly steady as continuing losses widened; client wins and Project GANGA advanced.HGS
Q1 26/27